top of page

Cure Mito Foundation announces a formation of a Corporate Advisory Council

Cure Mito Foundation, in collaboration with five of the industry’s prominent rare disease companies - PTC Therapeutics, Inc., Astellas Pharma US, Saol Therapeutics, Standigm, and Abliva AB, today announced the launch of a unique Corporate Advisory Council (CAC).

Please learn more in the press release:

59 views0 comments


bottom of page